Literature DB >> 12097594

Identification of rotavirus VP6 residues located at the interface with VP2 that are essential for capsid assembly and transcriptase activity.

Annie Charpilienne1, Jean Lepault, Felix Rey, Jean Cohen.   

Abstract

Rotavirus has a complex triple-layered icosahedral capsid. The external layer consists of VP7 and VP4, the intermediate layer consists of VP6 trimers, and the internal layer consists of VP2. Double-layered particles (DLP) derived from the virus by solubilization of VP4 and VP7 are transcriptionally competent and extrude capped mRNA from their vertices. Analysis of the pseudoatomic model of the VP6 layer, obtained by placing the atomic structure of VP6 into electron microscopy reconstructions of the DLP, has identified the regions of the protein involved in interactions with the internal layer. To study the role of VP6 both in the assembly of DLP and in transcription, 13 site-specific substitution mutations of VP6, targeting the contacts between the two inner layers, were constructed and expressed in the baculovirus system. The effects of these mutations on VP6 expression, trimerization, and formation of macromolecular assemblies were investigated. Using either in vitro reconstituted DLP derived from purified viral cores and recombinant VP6 or in vivo self-assembled virus-like particles resulting from the coexpression of VP2 and VP6 in the baculovirus-Sf9 system (VLP2/6), we have identified the amino acids essential for recovery of transcription or assembly. All VP6 mutants formed stable trimers which, like wild-type VP6, assembled into tubular structures. The ability of VP6 to interact with VP2 was examined by several assays, including electron microscopy, coimmunoprecipitation, purification of VLP2/6, and monitoring of the transcriptase activity of reconstituted DLP. Of the 13 VP6 mutants examined, 3 were unable to assemble with VP2 and 3 others partially assembled. These mutants either did not rescue the transcriptase activity of core particles or did so only marginally. Four mutants as well as the wild-type VP6 assembled and transcribed very well. Three mutants assembled well on cores but, surprisingly, did not rescue the transcriptase activity of reconstituted DLP. Our results indicate that hydrophobic interactions between VP6 and VP2 residues are responsible for the stability of the DLP. They also show that subtle electrostatic interactions between VP6 and the underlying transcriptase machinery can be essential for mRNA synthesis.

Mesh:

Substances:

Year:  2002        PMID: 12097594      PMCID: PMC136406          DOI: 10.1128/jvi.76.15.7822-7831.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Localization of group-specific epitopes on the major capsid protein of group A rotavirus.

Authors:  E Kohli; L Maurice; J F Vautherot; C Bourgeois; J B Bour; J Cohen; P Pothier
Journal:  J Gen Virol       Date:  1992-04       Impact factor: 3.891

2.  Nucleotide sequence of gene 5 encoding the inner capsid protein (VP6) of bovine group C rotavirus: comparison with corresponding genes of group C, A, and B rotaviruses.

Authors:  B Jiang; H Tsunemitsu; J R Gentsch; R I Glass; K Y Green; Y Qian; L J Saif
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

3.  Expression of the major capsid protein VP6 of group C rotavirus and synthesis of chimeric single-shelled particles by using recombinant baculoviruses.

Authors:  G Tosser; M Labbé; M Brémont; J Cohen
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

4.  Rotavirus VP3 expressed in insect cells possesses guanylyltransferase activity.

Authors:  M Liu; N M Mattion; M K Estes
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

5.  Three-dimensional visualization of mRNA release from actively transcribing rotavirus particles.

Authors:  J A Lawton; M K Estes; B V Prasad
Journal:  Nat Struct Biol       Date:  1997-02

6.  Deletion mapping of functional domains in the rotavirus capsid protein VP6.

Authors:  J L Affranchino; S A González
Journal:  J Gen Virol       Date:  1997-08       Impact factor: 3.891

Review 7.  Rotavirus gene structure and function.

Authors:  M K Estes; J Cohen
Journal:  Microbiol Rev       Date:  1989-12

8.  In vitro reconstitution of rotavirus transcriptional activity using viral cores and recombinant baculovirus expressed VP6.

Authors:  E Kohli; P Pothier; G Tosser; J Cohen; A M Sandino; E Spencer
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  The concentration of Ca2+ that solubilizes outer capsid proteins from rotavirus particles is dependent on the strain.

Authors:  M C Ruiz; A Charpilienne; F Liprandi; R Gajardo; F Michelangeli; J Cohen
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

10.  Nucleotide sequence of bovine rotavirus gene 1 and expression of the gene product in baculovirus.

Authors:  J Cohen; A Charpilienne; S Chilmonczyk; M K Estes
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

View more
  23 in total

1.  Rotavirus virus-like particles as surrogates in environmental persistence and inactivation studies.

Authors:  Santiago Caballero; F Xavier Abad; Fabienne Loisy; Françoise S Le Guyader; Jean Cohen; Rosa M Pintó; Albert Bosch
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

2.  Mechanism of intraparticle synthesis of the rotavirus double-stranded RNA genome.

Authors:  Kristen M Guglielmi; Sarah M McDonald; John T Patton
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

3.  Interaction of a host protein with core complexes of bacteriophage phi6 to control transcription.

Authors:  Xueying Qiao; Yang Sun; Jian Qiao; Leonard Mindich
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

4.  Use of rotavirus virus-like particles as surrogates to evaluate virus persistence in shellfish.

Authors:  Fabienne Loisy; Robert L Atmar; Jean-Claude Le Saux; Jean Cohen; Marie-Paule Caprais; Monique Pommepuy; Françoise S Le Guyader
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

5.  Genome heterogeneity of SA11 rotavirus due to reassortment with "O" agent.

Authors:  Catie Small; Mario Barro; Thomas L Brown; John T Patton
Journal:  Virology       Date:  2006-10-23       Impact factor: 3.616

6.  Identification of a Small Molecule That Compromises the Structural Integrity of Viroplasms and Rotavirus Double-Layered Particles.

Authors:  Catherine Eichwald; Giuditta De Lorenzo; Elisabeth M Schraner; Guido Papa; Michela Bollati; Paolo Swuec; Matteo de Rosa; Mario Milani; Eloise Mastrangelo; Mathias Ackermann; Oscar R Burrone; Francesca Arnoldi
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

7.  Role of host protein glutaredoxin 3 in the control of transcription during bacteriophage Phi2954 infection.

Authors:  Jian Qiao; Xueying Qiao; Yang Sun; Leonard Mindich
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

8.  Reverse Genetics Approach for Developing Rotavirus Vaccine Candidates Carrying VP4 and VP7 Genes Cloned from Clinical Isolates of Human Rotavirus.

Authors:  Yuta Kanai; Misa Onishi; Takahiro Kawagishi; Pimfhun Pannacha; Jeffery A Nurdin; Ryotaro Nouda; Moeko Yamasaki; Tina Lusiany; Pattara Khamrin; Shoko Okitsu; Satoshi Hayakawa; Hirotaka Ebina; Hiroshi Ushijima; Takeshi Kobayashi
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

9.  Group A human rotavirus genomics: evidence that gene constellations are influenced by viral protein interactions.

Authors:  Erica M Heiman; Sarah M McDonald; Mario Barro; Zenobia F Taraporewala; Tamara Bar-Magen; John T Patton
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

10.  Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein.

Authors:  Irina Tretyakova; Rachmat Hidajat; Garrett Hamilton; Noah Horn; Brian Nickols; Raphael O Prather; Terrence M Tumpey; Peter Pushko
Journal:  Virology       Date:  2015-11-02       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.